PGTI-0306 based therapeutics (Phenogene Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePGTI-0306 based therapeutics (Phenogene Therapeutics)
Drug Alias Namehypophosphatemia therapeutics (Phenogene Therapeutics)osteoporosis therapeutics (Phenogene Therapeutics)PGTI-0186
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBone metabolism modulators
TargetsUpdating
Therapy Area/IndicationsHypophosphatemiaOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhenogene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhenogene Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypophosphatemiaOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A